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ABSTRACT  
   
Many natural interventions have been effective at lowering postprandial glucose 
concentrations (PPG) in research trials and, theoretically, should have favorable effects 
on the prevention and management of T2DM. Natural interventions include vinegar, nuts 
and exercise. Green tea has been demonstrated to also possessing antiglycemic effects. 
Thus, green tea, and its most abundant catechin EGCG, are being consumed for its 
potential health benefits in cancer prevention and in its inhibitory effects on α-amylase. 
Many studies have found EGCG to inhibit α-amylase an enzyme needed in the 
breakdown of carbohydrates (CHO). Other studies have looked at EGCG and its potential 
for lowering PPG concentrations due to its inhibitory effects on α-amylase in both mice 
and humans. Yet there is no research on Matcha tea specifically. Matcha tea is green tea 
in powder form; hence, it is consumed in its entirety unlike traditional teas which are 
steeped in bags. The purpose of this study was to determine whether Macha tea impacts 
PPG concentrations in healthy adults. Twelve subjects completed this randomized 
controlled, single blinded, crossover study. On three separate occasions the twelve 
subjects consumed a bagel and jam with either water, Lipton green tea, or Macha tea. 
Fasting blood glucose was taken upon their arrival. Once the tea or water and bagel with 
jam were consumed PPG concentrations were measured every 30 minutes until 120 
minutes were reached. Results showed no statistically significant effects on PPG 
concentrations in either test groups (p=.960). However, this study did not measure EGCG 
levels in the tea provided. Therefore, further research should be done with known EGCG 
amounts to see its effects on PPG concentrations to fully rule out its potential.  
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CHAPTER 1 
INTRODUCTION 
 
Diabetes is a growing problem worldwide.  In 1995 it was estimated that there 
were 135 million people with diabetes with the expectation that it would grow to 300 
million in 2025.37, 52 Sadly, this estimation has underestimated the growing rate of 
diabetes worldwide as there are currently 422 million individuals with diabetes.92 
Recently diabetes had been estimated to increase up to 592 million in 2035.62 Hence, it is 
important to develop strategies to slow this rate and help with the prevention of type 2 
diabetes. One strategy is to lower postprandial blood glucose concentrations.  
The body follows a tightly regulated glucose homeostasis. The brain is demanding 
and must have at least 200g/d of glucose. If blood glucose concentrations are below 40 
mg/dL, coma or death could take place.59 Conversely if blood glucose levels are too high, 
above 180 mg/dL, countinously for many years, renal failure and atherosclerosis may 
occur.59 Glucose homeostasis includes two important pancreatic hormones insulin and 
glucagon which regulate blood glucose to keep it from being too low or too high. 
However, food and lifestyle choices can create many problems in this system. The 
Western diet is characterized by foods with a high glycemic index (GI).23,59 When foods 
have a high glycemic index the sugar is absorbed fast, creating a spike of glucose in the 
blood. To compensate, insulin spikes as well to help lower the glucose levels and utilize 
the glucose. Postprandial blood glucose levels can indicate this response. High GI foods 
include refined starches like white bread, soda and instant rice. When a high GI meal is 
consumed instead of a low GI meal, postprandial hyperglycemia throws off the system 
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and can take a toll on the pancreas which can lead to insulin resistance.59 Both 
postprandial hyperglycemia and insulin resistance increase the risk of type two 
diabetes.18,37,67 
Many studies have taken place to find different ways that will help lower 
postprandial blood glucose concentrations specially when eaten with high GI Foods. 
Delaying gastric emptying and inhibiting enzymes to delay digestion and absorption are 
some ways to lower postprandial glucose. Numerous studies have found ways to 
potentially lower blood glucose levels through these mechanisms. This includes vinegar, 
nuts and exercise.48, 50, 69, 71 There have also been a number of studies on dietary 
polyphenols and its effects on postprandial glucose. One example would be tea. The 
number two beverage consumed worldwide is tea.13 Although there are different types of 
tea including white tea, black tea, oolong, and green tea they all come from one plant 
called Camillia Sinensis.13 Of all teas, green tea is where most of the focus has been. 
Green tea has four main polyphenols also known as catechins these are, (-)-
epigallocatechin (EGC), (-)-epicatechin-3-gallate (ECG), (-)-epicatechin (EC), and (-)- 
epigallocatechin-3-gallate (EGCG).13 Many animal and invitro studies have shown a 
strong link with green tea’s most abundant catechin EGCG and its inhibitory effects on α-
amylase.32,34,62 There have been very few studies that have tested green tea consumption 
and its effect on postprandial glucose in humans.48,67 One area that has been lacking is the 
study of Matcha tea and its effects on postprandial glucose. Matcha tea is green tea, but 
instead of seeping the leaves the leaves are in powder form and consumed whole. This 
will allow every unique nutrient of green tea to be completely consumed. Therefore, it is 
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possible that Matcha tea will help lower postprandial glucose concentration when 
consuming starches.  
 
THE STUDY PURPOSE 
The studies objective was to measure the acute effect of Matcha tea on postprandial blood 
glucose levels in healthy adults. In this randomized controlled cross-over study the 
subjects will visit on three different occasions. The subjects will randomly be assigned to 
consume three different drinks [water, Lipton green tea, or Matcha tea]. At each lab visit, 
one of the beverages stated above will be consumed with a bagel and jam. Blood glucose 
levels will be measured every 30 minutes to 120 minutes, including the measurement at 
time 0.  
RESEARCH HYPOTHESES 
Match tea consumption with a meal will lower postprandial glucose levels in healthy 
adults as compared to Lipton tea or water.  
 
DEFINITION OF TERMS 
• Postprandial blood glucose- The 2-hr blood glucose area-under-the-curve 
following meal ingestion  
• Insulin- a hormone that functions to reduce blood glucose concentrations 
following meal ingestion 
• Glucagon- a hormone that functions to increase blood glucose concentrations 
between meals 
• Glycemic index- a ranking of different foods based on glycemic response, Scale 
from 0 to 100 those with High GI are foods that spike glucose in the blood at a 
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fast rate and are given a higher number, which is compared to the reference point 
of 100 which is pure glucose.  
• Polyphenol- a chemical found in many plant foods that can alter metabolism; 
may play a role in the prevention of diseases like cancer 
 
LIMITATIONS AND DELIMITATIONS 
• Limitations of this study are small sample size and the possibility of inappropriate 
study adherence. Glucometers need to be used properly which includes calibrating 
the glucometer before each use. Lastly, the amount of EGCG was unknown in 
both Matcha tea and Lipton green tea, therefore we do not know how much 
EGCG the subjects consumed.    
• Delimitations, this study excluded those with chronic diseases such as diabetes or 
cardiovascular disease and those on a weight loss program or taking any 
prescription medications for weight loss or any medications that may affect blood 
glucose levels. There were no imitations on weight. The ages of the subjects 
ranged from 20 to 31. These subjects are healthy adults therefore; this study may 
not be applicable for those with prediabetes or diabetes.     
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CHAPTER 2 
REVIEW OF THE LITERATURE  
This chapter will review the digestion and absorption of carbohydrates and 
glucose homeostasis. The glycemic index (GI) and glycemic load (GL) of foods will be 
defined and their effects on the body and disease states. Different interventions to help 
lower postprandial glucose concentration (PPG) including drugs, vinegar, nuts and 
exercise will be assessed. Finally, this chapter will highlight green tea and their healthful 
components, particularly the catechins. Specifically, Matcha tea will be highlighted with 
the focus on the catechin EGCG and its inhibitory effects on α-amylase and its potential 
for lowering PPG concentrations in humans.      
CHARBOHYDRATE DIGESTION AND ABSORBTION   
Carbohydrates (CHO) are made up of monosaccharides, basic unit of simple 
sugar. These include fructose, galactose, and the very important glucose. These 
monosaccharides can link together and form disaccharides. Lactose is composed of 
glucose and galactose and it is present in milk and dairy products. Sucrose is composed 
of glucose and fructose and is found in table sugar. Maltose is composed of two units of 
glucose and is found in molasses.  Also, many glucose units can bond together and make 
polysaccharides.  The common digestible polysaccharides are starch. Starch is found in 
plants and is made up of amylose and amylopectin which is composed of repeated 
glucose units that are bonded together.40, 82 The glucose in amylose is bonded together in 
a linear form bonded at the α (1-4) glyosidic bonds.40, 82 Amylopectin is also made up of 
glucose at α (1-4) glyosidic bonds, but then branch out, and these branch points are α (1-
6) glyosidic bonds.40, 82 Glycogen is also a polysaccharide and is stored in animal tissue 
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such as liver and skeletal muscle. Glycogen is a highly branched polysaccharide made up 
of glucose.40 The importance of storing glycogen is to have glucose readily accessible 
when glucose levels become low in the blood. Enzymes cleave the bonds to release 
glucose molecules which are used for energy through glycogenolysis.40 Lastly, cellulose 
is a polysaccharide found in plants cell walls. Cellulose is made up of many glucose 
molecules, but what makes it unique is how they bond together. Glucose is bonded at the 
β (1-4) glyosidic bonds, making it impossible to digest because humans do not possess 
the enzymes needed to break it down.40 Therefore, cellulose is a source of dietary fiber 
(undigested polysaccharides) and gives the stool bulk. 
 Polysaccharide digestion begins in the mouth with the enzyme salivary α-
amylase.40, 55, 82 This enzyme breaks down the polysaccharides at the α (1-4) glyosidic 
bonds, and a few mono or disaccharides are released before swallowing.40 Once the food 
enters the stomach the salivary α-amylase continues to do its job until gastric acid 
reduces enzymatic activity. The polysaccharides move from the stomach to the small 
intestine, duodenum and jejunum. At this point, pancreatic α-amylase is available to 
breakdown the polysaccharides amylose and amylopectin at the α (1-4) glyosidic bonds. 
40,55, 82 This produces oligosaccharides, which contain three to ten monosaccharides. The 
oligosaccharides continue to be digested into monosaccharides by other enzymes found 
on the brush border, called lactase, sucrase, maltase, isomaltase, and trehalase. 40, 55, 82 
Lactase takes lactose and breaks it down to glucose and galactose, sucrase breaks down 
sucrose to glucose and fructose, maltase breaks down maltose to produce two glucose 
molecules, and isomaltase breaks down the branch points of amylopectin into two 
glucose molecules.40 
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After the digestion of starches to monosaccharides and a few disaccharides, the 
absorption process can occur. The wall of the small intestine is made up of microvilli also 
known as the brush border.40 The brush border helps in the absorption process. The main 
goal is to move the monosaccharides like glucose from the lumen of the small intestine 
into the intestinal mucosal cell or enterocytes for absorption into the blood.40 Different 
transporters are used to move glucose, galactose, and fructose into the mucosal cell.40 
Glucose and galactose are absorbed into the enterocyte through active transportation. 
This transportation needs energy (ATP).40 The glucose galactose receptor is known as 
sodium-glucose transporter 1 (SGLT1).25, 40 This transporter takes glucose or galactose 
and a molecule of sodium into the enterocyte.25 Glucose, and galactose can also be 
absorbed through GLUT2 into the enterocyte.25, 40 Following a high CHO meal, the 
amount of glucose in the small intestine is elevated which leads to the activation of 
GLUT2 into the apical membrane. When this occurs, facilitated transport is used and 
ATP is not needed.40, 50 Fructose absorption into the enterocytes is primarily through 
facilitated transport using GLUT5 receptor.40, 50 All monosaccharides leave the enterocyte 
and enter the blood through GLUT2.25, 40 Once in the blood the monosaccharides are 
taken to the liver. Fructose and galactose are metabolized by the liver. These 
monosaccharides can be converted into glucose and can be used in many ways:40 stored 
as liver glycogen, circulate as blood glucose, or oxidized in the liver for energy. The 
glucose that has been sent to the liver can also go through all three processes stated 
above, but the surplus is sent into the systemic blood supply.40  
Glucose is then utilized by other tissues like kidneys, brain, muscles and adipose 
tissue.6, 40 Some tissues will require insulin for glucose uptake like skeletal muscle and 
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adipose cells through GLUT4 (insulin dependent).40 While other tissues like liver, brain 
and kidney do not need insulin to obtain glucose from the blood. GLUT1 is expressed in 
the erythrocytes, central nervous system, the brain and placenta for glucose uptake.40 
GLUT2 can be found in the liver, kidney, small intestine and β cells of the pancreases.87 
GLUT3 can be found in the brain/neurons, placenta and preimplantation embryos.6, 40 
GLUT5 only for fructose uptake can be found in the intestine, kidney, brain, skeletal 
muscle and adipose tissue.40, 50 
HOMIOSTASIS OF BLOOD GLUCOSE  
 Homeostasis of blood glucose concentrations is very important during fasting and 
postprandial period. If glucose falls below 40 mg/dL coma or death can occur.59 If 
glucose levels become too high over 180 mg/dL continuously for many years, renal 
failure and atherosclerosis may occur.59 Two important hormones involved in glucose 
homeostasis are insulin and glucagon. Insulin is a hormone secreted by the β-cells of the 
pancreas. A major manner for maintaining glucose homeostasis after a meal is the 
secretion of insulin when glucose concentration increases in the blood. Insulin will stop 
the production of glucose (gluconeogenesis) in the liver and lower the secretion of 
glucagon. Glycogen production from glucose is also stimulated. Insulin upregulates 
GLUT4 receptors in skeletal/cardiac muscles and adipose tissue. Facilitating glucose 
uptake by these cells to be used for energy. Glucagon is secreted by the α-cells of the 
pancreas when glucose concentration becomes too low during fasting or postoperative 
state. Glucagon sends a message to breakdown glycogen stores, this process is known as 
glycogenolysis to increase blood glucose concentrations.40 A glucose tolerance test can 
help determine those with normal, impaired or diabetic PPG responses after a meal or 
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consumption of a high sugar beverage. Normal glucose concentrations are defined in 
table 1.  
GLYCEMIC INDEX AND GLYCEMIC LOAD 
The amount and type of dietary carbohydrates impact the control of blood glucose 
homeostasis. The glycemic index (GI) and glycemic load (GL) are used to portray the 
impact of dietary carbohydrates on glucose homeostasis after meal consumption.59 When 
foods have a high glycemic index the carbohydrates are rapidly digested and absorbed 
quickly, creating a spike of glucose and insulin in the blood.59, 91 When foods are digested 
and absorbed slowly they have a low glycemic index and a more moderate rise in glucose 
and insulin concentrations.59, 91 To calculate the GI a subject consumes 50 g of glucose or 
50 g of avalible carbohydrate in a test food on separate occasions. The test food can be 
grains, legumes, fruit or vegetables. The purpose is to get an idea of the effects of 
carbohydrates on PPG after 2 hours compared to the 50 g of glucose which has a GI of 
100. Foods are classified as low GI [55 or less (oatmeal, pasta, sweet potato)] medium GI 
[56-69 (whole wheat bread, quick oats)] or High GI [70 or more (white bread or bagel, 
cornflakes)].40, 68 Glycemic load is also important in glycemic response. GL is calculated 
using the GI multiplied by the grams of carbohydrate consumed this formula takes into 
account the quantity and quality of a carbohydrate.91 GL is important when looking at 
different starches. That is, two starches may have a high GI but depending on how many 
carbohydrates that are available is important. For example, both watermelon and a 
doughnut have a GI of 76 which is high. However, one serving of watermelon is 11g of 
carbohydrates while a doughnut has 23g per serving.69 When using the formula above the 
GL of watermelon and doughnut is 8 and 17 respectively. A high GL is ≥ 20, medium is 
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11-19 where the doughnut falls, and a low GL is ≤ 10, where the watermelon falls.69 It is 
important to look at both GI and GL when it comes to the glycemic response, both will 
help determine its potential effects on PPG concentrations and insulin levels.  
TYPE OF STARCH 
A high or low glycemic index can depend on the type of starch. Starches can be 
classified into three categories which depends on how long digestion takes and the 
amount that can be digested. The three categories include rapidly digestible starch (RDS), 
slowly digestible starch (SDS), and resistant starch (RS).28, 30 RDS is quickly digested 
and absorbed in the small intestine. These starches include bread and potatoes and are 
converted into glucose in up to 20 minutes of enzymatic digestion.79 SDS are digested 
slowly as well as completely in the small intestine. These starches can be found in cereals 
and take up to 100 minutes to be broken down into glucose.79 RS is fermented by the gut 
microflora and not digested in the small intestine. This is the Starch that cannot be 
digested.28 RS can be further broken down into 5 classes. Type 1 starches are resistant to 
digestion because they are trapped by cell walls and protein matrix making it impossible 
to utilize them. These starches include partly milled grains and legumes.9, 28 Type 2 
resistant starch is found in raw potatoes and green unripe bananas. When raw the RS 
cannot be digested due to their resistance to enzymatic hydrolysis.9, 28 When a potato for 
example is cooked the starch significantly increases in digestibility due to starch 
gelatinization. Although, it is important to note that some starches in this classification 
may have a higher temperature needed for gelatinization to occur.9 Type 3 starches are 
found in foods like potatoes and rice that, when cooked are gelatinized, but then when 
cooled the gelatinized starches are turned into RS. The process of digestible gelatinized 
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starched that are cooled and converted into RS is called retrogradation; these products 
cannot be broken down by pancreatic amylase.9, 28, 79 Type 4 starches are modified by 
cross-linking or adding chemical derivatives. Both prevent enzymatic hydrolysis.9, 28 
Type 5 starches result from the interaction of lipids and starches to create a RS that can 
resist enzymatic hydrolysis, either by preventing amylase from breaking the starches 
down or by preventing gelatinization of a starch.9 Therefore, starches with more SDS and 
RS will have a lower GI and will have a lesser effect on blood glucose concentrations.  
The type of starch is not the only factor that effects the GI. Other factors include 
the acids and fat in foods which can slow down the process of stomach emptying. Slower 
stomach emptying can lead to a low GI because the rate of CHO digestion is slower. 
Particle size can affect the GI as well. If starchy foods are grounded up it can allow 
digestive enzymes to breakdown starches faster and therefore increase the GI.28 
GLYCEMIC INDEX AND GLYCEMIC LOAD LINKED TO DIABETES AND ITS 
PREVENTION  
Different theories exist in support of what mechanisms may cause type 2 diabetes. 
The two mechanisms include decrease pancreatic function from either excessive increase 
of insulin secretion or toxicity to the β cells from glucotoxicity and lipotoxicity. 59, 91 
Both mechanisms point to the main culprit of a high GI/GL meals.  
In the late postprandial period after a high GI meal there are low glucose and fatty 
acids in the blood which are important metabolic fuels, this can activate counter-
regulatory hormones to fix these low levels of metabolites in the blood.59, 91 
Glycogenolysis (breakdown of glycogen to free glucose) and gluconeogenesis 
(production of glucose) are both stimulated which increase hepatic glucose output.  The 
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stimulation of lipolysis (breakdown of adipose tissue to free fatty acids) elevates free 
fatty acids well above the levels of a low GI meal.59 The increased levels of glucose and 
lipids in the blood from a high GI/GL meal may be toxic to the pancreas or cause 
pancreatic exhaustion from increased insulin demand. During the late postprandial period 
of a low GI meal no counter-regulatory hormones would occur, and there would be a 
balance of glucose and free fatty acids in the blood with no need to increase hepatic 
output.59 The constant cycle of hyperglycemia, hyperinsulinemia and elevated free fatty 
acids from a high GI and GL diet could potentially damage the beta cells of the pancreas 
and increase the risk of T2DM. 
The GI and GL of foods is the leading factor that effects postprandial glycemic 
response. Many studies have looked at diabetes prevention and lowering postprandial 
glycemic response. Studies have found that a low GI and GL diet and the associated 
lower postprandial glycemic response is linked with a decrease risk of diabetes.10, 4, 49, 80, 
91 In the Nursing Health Study which is a large prospective epidemiological study of 
women had found that women consuming foods from with the highest GL increased their 
risk of T2DM by 40% compared to those who consumed foods in the lowest GL 
ranges.80, 91 One meta-analysis examined 8 studies which focused on diabetes risk factors, 
6 of the studies found an association to diabetes and 2 did not.10, 4 Findings in the meta-
analysis showed that a high GI or GL was an independent factor in increasing the risk of 
T2DM.10, 4 Other studies focused on nut consumption and T2DM. One study found that 
those who consume nuts had a lower risk of T2DM.46 The relative risk was 0.78 for those 
who consumed nuts at least 5 times per week compared to those who did not consume 
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nuts.46 This could be due to nuts effects on slowing down gastric emptying and therefore 
decreasing postprandial glucose concentrations.10, 49 
DIABETES PREVELANCE 
Table 1: Diabetes and Prediabetes Defined  
Disease State  A1C 
Fasting Plasma 
Glucose 
Oral Glucose 
Tolerance Test 
(OGTT) 
Diabetes  ≥ 6.5% ≥ 126 mg/dl ≥ 200 mg/dl 
Prediabetes 5.7 to 6.4% 
100 mg/dl to 125 
mg/dl 140-199 mg/dl 
Normal < 5.7%   < 100 mg/dl < 140 mg/dl 
diabetes.org 
Type two diabetes mellitus (T2DM) has been growing at alarming rates. In 2013, 285 
million people world-wide had T2DM. It had also been estimated that by 2030, 522 
million worldwide will have T2DM.7 In addition, prediabetes encompasses 79 million 
people in the US in 2013.7 Diabetes is a huge problem due to increased risk of morbidity 
and mortality from microvascular and macrovascular complications. Microvascular 
complications include retinopathy, nephropathy, and neuropathy while macrovascular 
complications include heart attacks, strokes, and peripheral vascular disease. 
Hyperglycemia plays a large role in microvascular and macrovascular complications.21 
Healthcare cost are also greatly affected by this disease. Treating diabetes and its 
complications in 2007 cost $174 billion, a number that is estimated to double by 2050.21 
Early detection of T2DM is key because morbidity and mortality increase due to long 
term complications. For those diagnosed with prediabetes it is the optimal time to start an 
intervention and treatment plan to reverse pathophysiological defects that occur.21 Diet 
and exercise is key in the prevention of insulin resistance, prediabetes, and diabetes.  
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INSULIN RESISTANCE  
When a high carbohydrate meal is consumed and digested, the glucose in the 
lumen of the small intestine is absorbed using GLUT2 into the enterocyte.40 The insulin 
that follows a spike in blood glucose concentrations down regulates GLUT2 to decrease 
the absorption of glucose. With insulin resistance, GLUT2 will remain upregulated and 
glucose will continue to absorb into the enterocyte and into the blood.40 Muscles and 
adipose tissue are also affected. GLUT4 is an insulin dependent receptor since insulin is 
needed for GLUT4 to be brought up onto the cell membrane.22, 40 If these cells are 
resistant to insulin it will prevent the uptake of glucose from the blood. Due to insulin 
resistance, glucose concentrations remain elevated in the blood. Gluconeogenesis and 
glycogenolysis both contribute to endogenous glucose production.95 Both can be utilized 
in the fasted state and when glucose concentrations are low. Glycogenolysis is the 
breakdown of glycogen to glucose to increase blood glucose concentrations. 
Gluconeogenesis is when glucose is produced using lactate, pyruvate, glycerol and 
branched chain amino acids.73 This occurs when glycogen stores are low. With insulin 
resistance increased gluconeogenesis occurs contributing to elevated fasting blood 
glucose concentrations.76 Insulin resistance also affects adipose tissue. Hormone-sensitive 
lipase can be found in adipose tissue which breaks down fat stores into free fatty acids 
(FFA) to be used for energy. Insulin inhibits this enzyme in a healthy individual. For 
those with insulin resistance, insulin loses its effects on inhibiting hormone-sensitive 
lipase therefore increasing FFA levels circulate in the blood.73, 85 Studies have found that 
FFA may have negative effects on insulin in the suppression of endogenous glucose 
production.76 One study found that when FFA were increased in the blood 
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gluconeogenesis also increased and vice versa, which could be a factor in hepatic insulin 
resistance and increased endogenous glucose production.95 The gold standard in 
measuring insulin resistance is a hyperinsulinemic-euglycemic clamp51, 85 which 
measures the action of insulin and glucose metabolism.51 Hyperinsulinemia is achieved 
with constant insulin infusion. Normal blood glucose concentrations are maintained via 
glucose infusion. The glucose infusion rate (GIR) is determined from blood glucose 
measurements taken every few minutes and adjusting the GIR.2 Good insulin sensitivity 
requires a greater GIR because the cells are responding to the insulin and the glucose is 
being taken into cells to be utilized.2 One study classified the different rates that indicate 
insulin resistance using the clamp. A glucose disposal rate (GDR) of < 5.6 mg/kg fat-free 
mass (FFM) + 17.7 ∙ min has an 80% chance of insulin resistance.85 The clamp is not 
normally used as a screening tool for individuals with prediabetes or diabetes, but rather 
commonly used in research. This is because the clamp is labor intensive and high in 
cost.65 Although, the hyperinsulinemic-euglycemic clamp is the gold standard there are 
other tools to assess insulin resistance this includes the homeostatic model assessment of 
insulin resistance (HOMA-IR). Where insulin sensitivity is measured by fasting plasma 
insulin and glucose concentrations and is plugged into an equation. Therefore, 
determining if a person is insulin resistant.   
PREDIABETES  
During the prediabetic state a decrease in β-cell function has already taken place. 
There are many contributing factors such as genetics, insulin resistance, increased insulin 
secretory demand, glucotoxicity, and lipotoxicity as well as decreased β-cell mass that 
play a role in the progression of β-cell dysfunction in the prediabetic stage.7 Together, 
  16 
these factors can lead to β-cell failure and diabetes.7 The diagnosis of prediabetes is based 
on impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG). IGT is 
characterized by early and late plasma insulin response when taking an oral glucose 
tolerance test (OGTT).21 In those with prediabetes moderate to severe muscle insulin 
resistance may be present. When the muscles cells are not responding to insulin they are 
not able to take in glucose. Excessive levels of blood glucose concentrations can occur 
with insulin resistance in the muscles. This is due to its high amounts of glucose uptake. 
One study showed with a hyperinsulinemia-euglycemic clamp that the glucose uptake of 
skeletal muscle is about 80%. The study also found that with an increase in insulin 
infusion increasing glucose uptake occurred in the leg muscles.22 Prediabetes is defined 
in table 1. Those with prediabetes also have altered triglyceride-rich lipoproteins 
metabolism. This manifests as high plasma triglyceride levels and low HDL-c. When 
there are higher amounts of triglycerides than needed the excess goes into the liver, 
skeletal muscle and pancreas which can result in lipotoxicity which contributes to β-cell 
dysfunction.7 It has been estimated that 5-10% of those who are prediabetic develop 
diabetes annually and 70% of those with prediabetes will eventually develop diabetes in 
their lifetime.7 Interventions that help reduce insulin demands and increase insulin 
sensitivity is important in preventing/delay the development of prediabetes to diabetes.21    
THE PROGRESSION OF NORMAL GLUCOSE LEVELS TO PREDIEBETIC TO 
TYPE TWO DIABETES 
Insulin resistance has been shown to start years before diabetes occurs. One study 
found that those who had diabetes showed increased glucose concentrations and 
decreased insulin sensitivity 13 years before they were diagnosed. Even though glucose 
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concentrations increased gradually they were still within the normal range until 2-6 years 
before diagnosis when there was a sudden increase in glucose levels.84 By 3 to 4 years 
before diagnosis insulin secretions increased and then plummeted. These findings help 
support the idea that insulin resistance can take place long before diagnosis.84 What may 
drive insulin resistance could be increase in weight, inactivity and genetics. There has 
been a 5-stage model in the development of diabetes by Weir. The first stage is called 
compensation where insulin resistance occurs and increased insulin secretion to keep 
glucose concentrations normal. This compensation of insulin most likely comes from 
increase in β-cell mass.84, 90 The second stage is called stable adaption where β-cell are 
not able to fully compensate and fasting glucose and post prandial glucose levels are not 
truly normal although they fall within the normal range. Both compensation and stable 
adaption stages occur before the prediabetic stage.84, 90 In stage three called unstable early 
decompensation, β-cells are not able to compensate and therefore glucose concentrations 
increase quickly. This stage most likely spreads from prediabetes to diabetes. The β-cells 
continue to show inadequate function, and glucose levels rise in a short period of time to 
stage 4 called stable decompensation. Further β-cell losses lead to stage 5 called sever 
decompensation which can include ketoacidosis and lead to insulin dependence.90 
DIABETES, MICROVASCUALR AND MACROVASCULAR COMPLICATIONS   
.  Diabetes occurs when β-cell dysfunction has occurred, and insulin can no longer 
compensate for high glucose concentrations. Diabetes is defined in table 1. Diabetes is 
characterized by hyperglycemia which wreaks havoc on the body leading to many 
complications.  These complications include microvascular like diabetic retinopathy and 
nephropathy and macrovascular complications like cardiovascular disease: 
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atherosclerosis, myocardial infractions, amputations and cerebrovascular disease like 
stroke.    
Diabetic Retinopathy (DR) is the leading cause of blindness in developed 
countries and effects 100 million people worldwide and can only go higher with 
increased diabetes rates.26, 81 DR develops as early as 7 years before the diagnosis of 
T2DM. DR may be related to the severity and duration of hyperglycemia. Hyperglycemia 
damage the capillaries and weaken them leading to the issues stated below.36 There are 
two categories of DR the first is the early stage called nonproliferative diabetic 
retinopathy this stage includes visible characteristics such as microaneurysms which is 
swelling of a vessel and appear as red dots in the back of the eye, retinal hemorrhages 
where the vessels of the retina burst and bleed and can lead to blurry or loss of vision.26, 36 
Nonproliferative diabetic retinopathy can lead to a loss of functional capillaries and 
inadequate blood flow called ischemia and lack of oxygen to retinal neurons which then 
progresses to the next stage.26 The advanced stage of DR is proliferative diabetic 
retinopathy where pathological preretinal neovascularization.26 This lack of blood flow 
leads to the retinal cells angiogenic signals like vascular endothelial growth factor 
(VEGF) which stimulates the growth of new vessels form previous vessels. The problem 
with neovascularization is that these new vessels can be fragile, leak and even grow into 
the vitreous which is the space between the lens and retina. Neovascularization can lead 
to vitreous hemorrhage causing severe vision loss.26 During both stages, diabetic macular 
edema (DME) takes place from the breakdown of the blood-retinal barrier due to diabetes 
due to leaky microvascular leakage and cause retinal thickening and edema of the macula 
and can cause vision loss.26, 36 One current treatment used in proliferative diabetic 
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retinopathy is Anti-VEGF and has been shown to reduce vision loss and increase vision 
gains. Hyperglycemia triggers the expression of VEGF which is linked with the 
breakdown of BRB, increased vascular permeability, and new vessel growth. Using Anti-
VEGF which inhibits VEGF has been shown to reduce vascular leakage and macular 
edema in those with diabetes.27 Anti-VEGF can also reduce new vessel growth which can 
help reduce damage to the retina from these new vessels and the issues that come with it 
like leakage or vitreous hemorrhage. Treatment for early stages of DR are still needed, 
increased pathophysiology’s for DR have been found but many treatments have not 
worked based on their findings.81 
 Diabetic Nephropathy (DN) is associated with three major changes in the 
glomeruli. Glomeruli is a cluster of capillaries that filters the blood. The major changes 
that take place include mesangial expansion, thickening of the glomerular basement 
membrane, and glomerular sclerosis. Mesangial expansion can potentially obstruct 
glomerular capillaries due to the expansion of mesangial matrix. Mesangial cells are 
important for maintaining the structure of glomerular capillary and regulate glomerular 
filtration by regulating blood flow though their ability to produce contractions.24, 43 
Hyperglycemia is linked with increased number and size of mesangial cells and increase 
in matrix production.24 This could occur due to increased glucose levels in the cell. The 
excess glucose from hyperglycemia can lead to an accumulation of glycation end 
products (AGE) which is protein and lipids molecules that bind to glucose. Healthy 
kidneys excrete AGEs but in kidney disease AGEs build up in the tissue and can be one 
reason for mesangial expansion and can also affect glomerular basement membrane and 
podocytes.24, 43, 83 Glomerular basement membrane is within the glomerulus. The 
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membranes lie between two cell types: glomerular endothelial cells and glomerular 
epithelial cells also known as podocytes which make up the glomerular filtration 
barrier.60 The glomerular basement membrane plays a role in glomerular filtration barrier 
which is the process of selective filtration of the blood. The glomerular filtration barrier 
allows free permeability of water and small solutes while preventing macromolecules and 
cells from leaving the blood leading to protein free urine. Podocytes maintain the 
structure and function of glomerular basement membrane and any alterations in any of 
the layers of glomerular filtration barrier which includes podocytes and glomerular 
basement membrane can change glomerular permeability.60 Hyperglycemia can increase 
the production of renin and angiotensin which increases angiotensin II. Angiotensin II 
has shown to increase activity in two growth factors VEGF-A and TGF-B. Both growth 
factors increase glomerular basement membrane thickening and mesangial expansion by 
depositing protein outside the cell and directly increasing proteinuria and disturbing 
glomerular filtration barrier.15, 43 The kidneys naturally produce reactive oxygen species 
(ROS) (i.e., O2
-,H2O2. NO, and ONOO
-) during metabolic activity. ROS production is 
usually corrected with antioxidant enzymes such as glutathioneperoxidase, catalase, and 
superoxide dismutase.83 ROS production is stimulated from hyperglycemia effecting the 
balance between ROS and the body’s ability to protect against ROS. ROS can greatly 
damage the kidneys, renal vasculature and potentially glomerular filtration barrier and 
podocytes through the damaging effects of ROS which include damage to the cells lipid 
membrane also known as peroxidation, oxidation of proteins, renal vasoconstriction and 
damage to DNA.24, 83 These changes in the kidneys from the effects of hyperglycemia, 
leads to kidney damage, albuminuria, and diabetic kidney disease. Of those with diabetes 
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20 to 40% develop DN. This is the most common cause of end stage renal disease and 
required dialysis in the US. Dialysis is a costly process and not easy on the body. Those 
with diabetes on dialysis have a 22% higher mortality risk after the initiation of dialysis.24  
Macrovascular complications occur from atherosclerosis which effects coronary 
arteries, peripheral arteries and carotid vessels. The formation of atherosclerosis is greatly 
affected by diabetes and increases the risk of its formation which can lead to coronary 
and peripheral artery disease as well as cerebrovascular disease. Cardiovascular disease is 
the leading cause of death in patients with diabetes because of the effects of 
atherosclerosis. Cardiovascular disease is responsible for 44% of deaths in those with 
diabetes.61 Peripheral artery disease (PAD) occurs from the formation of atherosclerosis 
in the vessels of the lower extremities. PAD is linked to loss of function of the legs, 
increases the risk of myocardial infraction, stroke, and limb loss. In the US diabetes is the 
number one reason for non-traumatic lower extremity amputations.5 The 12 million 
people in the US with PAD, about 20 to 30% have diabetes.61 Glycemic control in 
patients with diabetes is an independent risk factor of PAD. Every 1% increase in HbA1C 
increases PAD risk by 28%.61 Myocardial infraction increases the risk of recurrent 
myocardial infraction or cardiovascular death events by 18.8% in those who are 
nondiabetic whereas those who were diabetic had a 45% risk.5 Those with diabetes have 
an increased risk of stroke (+150% to 400%). Poor glycemic control directly relates to 
stroke risk.5 Cardiovascular disease and cerebrovascular disease are strongly driven by 
atherosclerosis. Diabetes exacerbates the rate of atherosclerosis increasing the risk of 
disability and death for patients with diabetes.    
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Atherosclerosis occur when lymphocytes and monocytes move to the intima of a 
vessel.5 Monocytes which turn into macrophages take in oxidized LDL-c and become 
foam cells.5 The accumulation of foam cells produces fatty streaks which is the beginning 
of atherosclerotic lesions. This pathological process is increased with diabetes. 
Hyperglycemia increases oxidative stress in the endothelium of the vessels and increases 
advanced glycation end products which leads to an increased production of nuclear factor 
KB (NF-KB).
5, 20 NF-KB can be found in atherosclerotic lesions and plays a role in 
atherosclerosis due to its regulation of inflammatory gene expression of cytokines, 
chemokines, leukocyte-cell adhesion molecules and acute phase proteins.5 The 
inflammatory gene expression brought on by the activation of NF-KB recruits 
lymphocytes and monocytes into the intima of the vessels bringing about the possible 
production of foam cells and fatty streaks.5, 20 Diabetes can also lead to plaque instability 
by decreasing collagen synthesis and increasing collagen break down. Collagen is very 
important in the stability of the fibrous cap. Studies have found that a thinner fibrous cap 
can increase the chances of plaque rupture.3, 5 Plaque rupture can result in thrombus 
(blood clot).3, 5, 61 The risk of thrombus is high in those with diabetes due to 
hyperglycemia and its effects on platelet activation. 5, 61 Hyperglycemia plays a role in 
atherosclerosis formation, plaque instability, platelet activation, and thrombus. Increasing 
the chances of blocking the flow of blood in a vessel leading to myocardial infraction, 
stroke or death.  
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INTERVENTIONS TO HELP PREVENT DIABETES  
 
In diabetes, glycemic control is an issue characterized by hyperglycemia and 
insulin resistance. Glycemic control and fasting blood glucose are greatly affected when 
hepatic insulin resistance is present. Metformin is a drug that can be used in the 
prevention or treatment of diabetes. Metformin decreases fasting blood glucose 
concentrations by decreasing hepatic glucose production. Metformin suppresses 
gluconeogenesis and enhances the action of insulin to inhibit endogenous glucose 
production.33, 35, 84 A randomized control trial evaluated the effects of metformin in 
subjects with IGT. IGT is a risk factor for T2DM.73 This study looked at how metformin 
could positively affect the rate of those with IGT to the progression of diabetes. There 
were 29938 subjects who were investigated at Shougang Corporation using 75g oral 
glucose tolerance test (OGTT). Those with IGT based on WHO criteria (1985) with age 
ranging from 30 to 60 years were eligible for the study. Those with pre-existing diabetes, 
history of ischemic heart disease, renal or hepatic disorders, and those previously treated 
with metformin were excluded. Subjects were randomized into two groups:  metformin 
(n=33) and placebo (n=37).  Both groups averaged 50 years in age with close to normal 
weights and BMI. This was a double-blinded RCT; subjects in the metformin group 
received 250 mg three times a day. All subjects in both groups received education on 
diet, exercise, and healthy lifestyle every 3 months. The study ran for a year with follow 
up visits every 3 months. Using a venous blood sample, fasting plasma glucose, HbA1C 
and insulin were measured. Urine was also collected to measure urinary albumin 
excretion rate (UAE). After 12 months the 28 subjects receiving metformin reverted to 
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NGT (84.9%) compared to 19 in the placebo group (51.4%) ( p-value =0.011). One 
subject in metformin group converted to T2DM (3.0%) while 6 subjects in the placebo 
group converted to T2DM (16.2%). By 12 months the placebo group displayed a 
decreased fasting blood glucose (mmol/l) from 7.3 ± 1.0 to 6.2 ± 1.3, and the metformin 
group displayed a decrease from 6.9 ± 0.9 to 5.0 ± 1.1 (P<0.01). HbA1c had a net fall of 
0.7% in the metformin group with a p-value of 0.0001 whereas in the control group there 
was no significant decrease in HbA1C, 7.4 ± 0.8 to 7.3 ± 0.9. A decrease in HbA1c in the 
metformin group could be related to improved fasting glucose concentrations and 
improved glucose tolerance.57 Insulin levels also decreased in the metformin group and 
significant improvements in insulin sensitivity was shown. Lastly, UAE for both groups 
were within normal limits, but those in the metformin group had a statistically significant 
decrease from baseline to 12 moths (P<0.05).  Metformin did show improvements in 
fasting blood glucose concentrations, insulin levels and even decreased UAE. Also, the 
conversion of IGT to T2DM was only 1 person in the metformin group and 6 in the 
placebo group. This study shows improvements in FBG, insulin levels and HbA1c which 
is very important in the prevention of T2DM especially for those with prediabetes.57  
 Metformin and lifestyle modifications were looked at in another RCT. The study 
looked at those with IGT and the incidence of T2DM in Asian Indians. Subjects in this 
study who had IGT was determined using 75g OGTT and defined as FBG <126 mg/d and 
2-h glucose 140-199 mg/d. Those who did show glucose concentrations that indicated 
IGT were tested twice to confirm. There were 532 subjects with IGT and were 
randomized into four different groups. Group 1 (n=136) the control, Group 2 (n=133) 
lifestyle modification (LSM), Group 3 (n=133) metformin (MET), and group 4 (n=129) 
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LSM and MET. Primary outcome was to see how many subjects developed diabetes 
which is either a FBG of ≥ 126 mg/dl and/or 2-h glucose ≥ 200 mg/dl using 75g OGTT. 
Subjects were given 250 mg two times a day of metformin initially. After two weeks, it 
was increased to 500 mg twice a day for 40 days and then brought back down to 250mg 
twice a day. Those subjects in the LSM groups received advice on a healthy diet and 
regular active. Diet modification included reduction of calories, refined CHO and fats as 
well as sugar and an increase in fiber-rich foods. This study took place for three years 
with an annual OGTT and anthropometric measurements. Those with blood levels that 
indicate diabetes were checked again. Results show that after three years the prevalence 
of diabetes was 55% in the control whereas the other groups did show a statistically 
significantly lower incident:  LSM was 39.3%, MET was 40.5% and LSM + MET was 
39.5%. Absolute relative risk was reduced significantly as well, LSM reduced risk 
28.5%, LET +MET 28.2% and MET 26.4%. These data show that metformin reduced the 
risk and progression of T2DM.75     
Other interventions have been found to help lower PPG concentrations. This is 
important due to its impact on the development of type 2 diabetes and cardiovascular 
disease. This includes both drugs and natural interventions. Drugs that helps lower PPG 
concentration are known as α-glucosidase inhibitors (AGIs).23 One example of this drug 
is Acarbose. This drug inhibits α-glucosidase; these enzymes are found in the brush 
boarder of the gut.23 They break down the oligosaccharides into monosaccharides to be 
absorbed into the enterocytes, so they can then enter the bloodstream.23 The inhibition of 
these enzymes will greatly affect the amount of monosaccharides that can enter the 
bloodstream, lowering PPG concentrations.  
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A randomized double-blinded and placebo-controlled was done in Canada, 
Germany, Austria, Norway, Denmark, Sweden, Finland, Israel and Spain. Men and 
women between 40 and 70 years in high risk populations with a BMI ranging from 25 to 
40 kg/m2 were screened. Those who were eligible for the study were those with IGT (2-h 
PG ≥ 140 mg/dl and < 200 mg/dl and a FPG of 100-138 mg/dl). Subjects were randomly 
selected to placebo (n= 686) and acarbose (n= 682). Subjects receiving acarbose started 
at 50 mg a day and then slowly increased to 100 mg three times a day. Subjects were to 
record a 3-day food diary and physical activity during the last month of their annual visit. 
Subjects were seen every 3 months for pill count and distribution as well as measuring 
FPG. This study took 3.3 years and their primary outcome was development of diabetes 
(2-hr PG of ≥ 200 mg/dl after 75g OGTT). The subjects from Canada made up 40% of 
the subjects, 27% Germany and Austria, 24% Nordic countries, 5% each from Spain and 
Israel. Results showed that acarbose reduced the risk of the developing T2DM by 25%. 
Acarbose also increased the chances of IGT to revert to NGT (p<0.0001). The reason for 
these results could be explained by the findings of other studies where the higher the 2-hr 
PPG concentration after 75g OGTT in those with IGT the higher the risk for T2DM. 
Acarbose helps lower PPG concentrations and therefore reducing the development of 
T2DM.16        
Natural interventions have also been able to lower PPG concentration as well. 
Vinegar is one natural intervention. The acetic acid in vinegar is effective in lowering 
PPG concentrations and insulin response in many studies.47, 58, 70 This could be due to the 
acetic acid which delays gastric emptying rate.58, 63 Therefore, polysaccharides enter the 
small intestine at a slower rate, preventing a spike in glucose. Other studies have also 
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found that acetic acid may inhibit disaccharidase.63 These enzymes are found in the small 
intestine, its inhibition can result in decreased glucose absorption due to the inability to 
breakdown sucrose, maltose, and lactose into monosaccharides.63 One study gave 
subjects a meal composed of a bagel with butter, juice and water. The GI of the bagel 
meal= 100. Before the meal was consumed, participants were given either a placebo 
drink or test drink that contained water and 20g of apple cider vinegar (close to a 
tablespoon) with 5% acetic acid.47 At 60 minutes post meal PPG concentration was 
lowered by 54% in comparison with the control of no vinegar consumption.47 
Another natural intervention is nut consumption and its effects on lowering PPG 
concentrations. In the study described above nuts were also examined. The test meal was 
the same, but instead of butter 25 grams of peanut butter was spread on the bagel.47 PPG 
concentrations were lowered by 56% in comparison with the butter control.47 Almonds 
also show similar effects when consumed with white bread in a different study.49 White 
bread was consumed with different amounts of almonds: 0g (control) or 30g, 60g, or 
90g.49 The greater the number of almonds consumed with the white bread the lower the 
PPG concentrations.49 The reason for the effects on nuts and PPG concentrations is due to 
its effects on gastric emptying. The higher the dose of almonds the slower the rate in 
gastric emptying and subsequently a decreased glycemic response.49   
Exercise is another intervention that can lower PPG concentrations.68,77 Two 
studies demonstrated that exercise for 90 minutes (moderate-intensity), 2 hours before or 
after meal, results in a 50% decrease of PPG concentrations.68 Being physically active 
has been found to lower blood glucose concentrations for up to 24 hours or longer.1, 77  
The reason why exercise help lower glucose concentrations is due to its positive effects 
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on insulin sensitivity.1 Increased sensitivity to insulin helps increase glucose uptake into 
muscle and moving it out of the blood stream.   
It is important to find more ways to help lower PPG concentrations in the 
prevention of insulin resistance, type 2 diabetes and cardiovascular disease. The more 
interventions identified the more tools that will be available to the public. Everyone is 
different, and one intervention does not fit all; therefore, the more interventions are 
proven the more people that can be helped.  
TEA 
There have been a number of studies on dietary polyphenols and their effects on 
PPG concentrations. One example would be tea. The number two beverage consumed 
worldwide is tea.13 Although there are different types of tea like white tea, black tea, 
oolong, and green tea they all come from one plant called Camillia Sinensis.13 This 
evergreen tree can reach 98 feet tall. This tea tree has its roots in Xishuangbanna, China 
where it still grows today. There are 200 species of Camillia, Camillia Sinensis is solely 
for tea production.38 The word Sinensis means from China, where tea was discovered.38 
The discovery of tea is explained in a mythical story of Emperor Shen Nung in 2737 
B.C.E. The story follows, Emperor Shen Nung was a scholar and herbalist. He only 
consumed boiling water for hygienic purposes. One-day Shen Nung was sitting under a 
tea tree, when the breeze caught the tree. The leaves on the swaying branches fell into his 
boiling water. When he drank this new “beverage,” he found it to be enjoyable as well as 
revitalizing. Thus, tea was discovered.72 
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TYPES OF TEA AND TEA PRODUCTION  
There are many different types of tea which all have their own unique production 
process. White tea is the least handled. White tea can be just the downy buds of the plant 
which produce tea like silver needle. It can also be a mixture of the buds and leaves of the 
tea tree which produces tea like Shou Mei. 38 The Chinese process white tea by withering 
the leaves and buds, which are spread out on racks. They are left to air dry if weather 
permits for 12 to 24 hours, or, fans can be used as well. 38 Then the leaves are sorted to 
remove broken leaves and branches and other unwanted products. For green tea, leaves 
are plucked young with their buds attached while other green teas use mature leaves 
without buds. The leaves also go through the process of withering to dehydrate the plant 
to reduce moister from the leaves. 38 Dehydrating tea leaves can inhibit enzymatic activity 
and therefore slow down the oxidation of the leaves.78 Tea leaves are left to air dry on 
racks or using a cylindrical machine that spins the leaves while blowing air on them.38 
Once the leaves are dried they go through the process of panning.38 the leaves are heated 
once again to decrease oxidation or stop oxidation all together using vats. The heat causes 
enzymes, polyphenol oxidase and peroxidase, which are responsible for oxidation to 
denature.39, 78 Pressing small batches of leaves to the bottom of the vat prevents the 
burning of the leaves. The leaves are subjected to three different heat/cooling cycles 
which gives the tea its unique properties like the release of the polyphenols and its 
aromatic smell. 38 The leaves are then rolled to release oils, also changing the shape of the 
leaves to twisted or bead-shaped. The leaves are then dried again so that the oils released 
from rolling will remain on the leaves and stabilize. Also, the drying process will further 
dehydrate the leaves leaving only 2 to 4% moister in the leaves. 38 The last part is sifting, 
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to remove any fine particles that could have happened from the leaves breaking, the 
leaves are then sorted into different sizes. 38 For black tea the withering of the leaves take 
place for 5 to 6 hours and are stirred often. When the leaves are mechanically processed 
they are heated by wood fires to give the tea a smoky aroma. Rolling takes place next to 
release enzymes that cause oxidation. This can be done using a machine to press the 
leaves down and release the enzymes. The oxidation of the leaves can take from 8 to 12 
hours. They are spread on ground covered by wet cloth, temperature should reach 72 
degrees Fahrenheit. 38 The leaves are then dried to eliminate moisture that remains in the 
leaves. This can be done using machines and blowing warm air on the leaves, or they can 
be added to another wood based heating process. Sorting and sifting of the leaves comes 
next. They separate the leaves into different grades while eliminating any unwanted 
product like branches. 38  
In Japan, green tea is processed differently. The leaves are plucked by machine 
and then steamed for about 20 to 80 seconds. This is important in terms of aromatic 
quality. Short bouts of steam produce a light taste reminiscent of green vegetables. 38 
While longer steaming (40 to 80 seconds) is more traditionally done in Japan giving the 
tea an intense flavor and darker liquid. 38 The tea leaves are steamed or heated 
immediately to denature the enzymes that cause oxidation.78 In turn the green color 
remains as it continues the step by step process.78 The tea leaves are then cooled by air 
jets while leaves rotate in cylinders. The first drying takes place at 210° Fahrenheit for 45 
minutes. Then they are moved into a different machine to be heated at 175° Fahrenheit 
and brought down to 105° Fahrenheit. The rotating cylinders used in this process are 
designed to brush the outside layer of the leave which determine the color of the leaves 
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and release the tannins. 38 The leaves are then rolled to release the oils and then a second 
drying takes place. This is done for 20 to 40 minutes at 80° Fahrenheit. After this 13% of 
water remain in the leaves. 38 Shaping is next, using machinery that give the leaves a 
needle shape which can last for 40 to 60 minutes at 158 to 248° Fahrenheit. 38 A third 
drying takes place on a conveyor belt for 30 minutes and heated to 185° Fahrenheit. 38 
Shifting and sorting is done to take branches and other unwanted product out and to sort 
by size. 38 The final drying process depends on the final product that is desired. Leaves 
are heated to 105° Fahrenheit for aromatic purposes. The longer the leaves are heated the 
fresh grass aroma decreases and is replaced by a smell more like grilled nuts. Only 1 to 
3% moister is left. 38 
Matcha tea started in China where it was custom to grind the leaves into a powder 
form. This method was adopted by the Japanese and became part of a ritual called 
Chanoyu. The high quality Matcha tea leaves come from Uji region of Japan. 38 The tea 
leaves go through the same process of Japanese green tea stated above but, the leaves are 
sorted strategically to permit grounding to a fine powder. 38 The preparation of Matcha tea 
is unique: 1) 1 tsp of Matcha using a strainer, sift the tea to prevent lumps 2) pour ¼ cup 
of water at temperature of 167 degrees Fahrenheit over tea then whisk. 3) when foam 
begins to form, raise whisk carefully 4) Drink the tea. To prepare the Matcha you will 
need a tea bowl, tea whisk, a teaspoon and a fine strainer. 38 
NUTRIENTS IN TEA  
All tea has its own unique make up that draws attention to many health benefits. 
The main tea would be green tea for the abundant polyphenol content and its link to many 
health benefits. The chemical composition of green tea is based on dry weight 15 to 20% 
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proteins 1-4% of these proteins are composed of amino acids like, theanine, glutamic 
acid, tyrosine, valine, leucine, threonine, arginine, and lysine.13 Carbohydrates 5-7%, 
including cellulose, glucose, fructose, sucrose, and pectins.13 Lipids include linoleic and 
α-linolenic acids. Sterols for example stigmasterol can be found in green tea and vitamins 
such as B, C, and E. Minerals include Calcium, Magnesium, Chromium, Manganese, 
Iron, Copper, zinc, molybdenum, selenium, sodium, phosphorus, nickel, potassium, and 
Aluminum.13 Studies have found different mineral content based on location of where the 
tea leaves have grown.13 As tea leaves are processed to form different kinds of tea the 
nutrient composition changes. There are for major catechins in green tea which include (-
)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin-3-gallate (ECG), and (-)- 
epigallocatechin-3-gallate (EGCG).38   Because green tea is the least oxidized these 
catechin’s remain high. In black tea which is completely oxidized the catechin are 
decreased and form theaflavins and thearubigins.56, 86 Tea also contains caffeine but in 
lower amounts compared to coffee. In 1 oz of coffee brewed prepared with water there is 
12 mg of caffeine and for 4 oz of coffee there is 47 mg of caffeine.88 In 1 oz of green tea 
brewed and unsweetened contains about 4 mg of caffeine and 16 mg of caffeine in 4 oz.88  
GREEN TEA AND ITS POTENTIAL EFFECTS FROM ITS ANTIOXIDANTS  
Green tea also contains polyphenols known as catechins. The four major catechins 
and their percentage of total catechin make are, (-)-epicatechin (EC) 6.4%, (-)-
epigallocatechin (EGC) 19%, (-)-epicatechin-3-gallate (ECG) 13.6%, and (-)- 
epigallocatechin-3-gallate (EGCG) 59%.38 The most abundant catechin in green tea is 
EGCG. Analysis of 31 commercial teas found that EGCG were greatest in old green tea 
leaves and then lessened with young leaves, oolong tea, and then black tea. It has also 
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been estimated that a cup of green tea which is 2.5 grams of tea leaves with 200 mL of 
water may contain 90 mg of EGCG.13, 93 
The most abundant catechin in green teas, EGCG, has been a focal point of 
interest in many studies particularly cancer studies. It has also been found to inhibit the 
enzyme α-amylase.32, 34As discussed earlier α-amylase can be found in the saliva and 
pancreas. One study on EGCG and its effects on PPG concentrations in mice was 
conducted at Pennsylvania State University.34 The male mice used were separated into 
groups based on body weight. The mice were given common corn starch, glucose, 
maltose or sucrose with 100 mg/kg of EGCG or without EGCG.34 An α-amylase 
inhibition assay by EGCG and EGC was also conducted in vitro. The results found that, 
the mice receiving EGCG and CCS had reduced blood glucose concentrations as 
compared to mice that did not consume EGCG with CCS.34 They found mean blood 
glucose concentrations decreased by 77 mg/dL within 30 minutes and 73 mg/dL lower 
after 60 minutes of consuming EGCG.34 These findings showed a statistically significant 
(p< 0.05) decrease in blood glucose concentrations in the mice receiving EGCG.34 There 
were no effects found from the glucose or maltose groups with the EGCG. The results 
from the α-amylase inhibition assay, showed EGCG and EGC did inhibit α-amylase, 
EGCG was found to have a stronger link in this. EGCG at 20 µM, inhibited α-amylase by 
34%.34 The study reports that the EGCG dosage was equivalent to 1.5 cups of green tea, 
which lowered PPG concentrations when taken in with common corn starch in mice.34 
Another study also found that EGCG is the main catechin to inhibit α-amylase.32 
This is because EGCG has shown a higher inhibitory power compared to other 
polyphenols.32 Using ultraviolet absorption spectroscopy and fluorescence emission 
  34 
spectroscopy the interaction of EGCG and α-amylase were assessed. The interaction 
entailed bondage at the hydroxyl group of the polyphenol and the catalytic residues of the 
binging sites in α-amylase.32 Hydrogen bonding and hydrophobic interactions bond the 
hydroxyl group of the polyphenol to the binding site on α-amylase.32, 94 This forms a 
polyphenols-enzyme complex resulting in the inhibition of α-amylase.32 
There have been few studies on green tea consumption and its effects on PPG 
concentrations in humans. There have also been very little or no studies on the effects of 
Matcha tea and PPG concentrations. Because there has been many animal and invitro 
studies assessing the inhibition of α-amylase from the catechin EGCG. It is important to 
further this knowledge and see if it can be applicable for human subjects. It is important 
to test Matcha tea, since instead of steeping the leaves for a few minutes in hot water and 
then removing the leaves, the leaves remain in the drink increasing the amount of 
polyphenols including EGCG that are ingested. Hence, since Matcha tea leaves are 
consumed whole more constituents are ingested which may facilitate efficacy. To study 
the effects of Matcha tea on PPG concentrations will add to the collection of tools in the 
prevention of these metabolic diseases.   
GREEN TEA AND HEALTH CLAIMS  
There are many health claims on green tea and its potential glucose lowering 
effects. Studies in mice may have shown the potential effects of EGCG extracts, but these 
results are not so comparable to green tea consumption in humans. Still, health claims 
have been made on the internet either adding miss-information or to help sell a product. 
One web article written on the website called Healthline, informs readers about green tea 
and diabetes management.74 The web article states the potential of green tea and 
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prevention of diabetes. The research used to support this statement had found that those 
who consumed 6 or more cups of green tea daily were 33% less likely to develop 
diabetes.42, 45 What this web article did not include was that this study also looked at 
coffee intake and found that 3 ≥ cups consumed daily was associated with a 42% lower 
risk for diabetes.45 The study by researcher Hiroyasu Iso et al, was a retrospective cohort 
which collected self-reporting data on how much coffee, green tea, black tea and oolong 
are consumed daily. Based on their answers they categorized the amount of caffeine 
consumed. The subjects also self-reported if they were diagnosed with diabetes by a 
physician. Self-reporting could affect the study greatly since there could be individuals 
with diabetes, but may not have been diagnosed. The study did find an inverse 
relationship between consumption of higher levels of caffeine from either coffee or tea 
and a decreased risk of diabetes.45 Although this study can be a stepping stone for 
research, more needs to be done. A randomized control trial is the gold standard and 
would provide more valid information. The web article also states that green tea may be 
able to help manage blood glucose levels in those with diabetes.74 They support this with 
a comprehensive review that pulls many tea studies together and assess the power of tea 
collectively and its effects on fasting glucose, A1C levels, and fasting insulin levels. 
When looking into this comprehensive review over 10 of the studies used tea extract. Tea 
extract can be very different than consuming tea itself because the concentration of 
polyphenols like EGCG can be much higher. This information can be very misleading 
when supporting tea drinking to help manage diabetes. This article also explains the 
reasoning on why green tea can be so beneficial using information from Pacific College 
of Oriental Medicine.71 The college talks about the potential effects of teas polyphenols. 
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Making claims that tea can help lower blood sugar concentrations supporting this with a 
study using tea extract, but not including any specific references to identify what study 
they wrote about.   
      
Another web article written on everyday health titled “Why Drinking Tea May 
help prevent and manage Type 2 Diabetes.”12 This article also mentioned the 
retrospective cohort study by Hiroyasu Iso et al. This article only shared the finding of 
green tea but did not mention that only 3 cups of coffee rather than 6 cups of tea would 
have a higher percentage in decreasing diabetes risk.45 This study was not a strong design 
since it was not a randomized control trial and relied on self-reporting. Also, the article 
makes a claim that polyphenols in green tea can help regulate glucose. There was no 
reference to support this statement. The only study that was mentioned was the one above 
and the only reason they found a decrease risk of diabetes is because of the caffeine 
content found in tea and coffee. Therefore, this article can be misleading and providing 
false information to its readers.  
 
Lastly, one website makes many claims on Matcha tea for diabetes.97 The web 
article mentions green tea and states that drinking Matcha tea is one way in preventing 
type 2 diabetes due to its high antioxidant content. The web article talks about Matcha tea 
being more potent and more effective in preventing and treating diabetes. Also, stating 
that Matcha helps absorb glucose and can reduce the amount of glucose in the blood. 
Although, there are no sources to support any of these statements. The web article also 
mentions catechins in green tea increase fat oxidation, improve exercise performance, 
and prevent obesity. The one study they referenced was by Venables et al. This study 
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used healthy men with above average VO2 max. The subjects were to take a placebo or 
green tea extract (GTE) 3 times before they would participate in 30 minutes of moderate-
intense physical activity.89 They found that when the men took GTE their fat oxidation 
was 35%, which was 5% higher than with the placebo.89 This was a statistically 
significant difference. They did not study fat oxidation and GTE at rest. Stating that green 
tea can help increase fat oxidation is not accurate since it was only found during exercise 
in healthy men using GTE supplementation rather than drinking tea. Those who read this 
may be misled since the web article on 1001 tea fact is about drinking Matcha tea and, 
yet the study used GTE supplements. Those in the study were also healthy fit men, but 
the readers of this article may be sedentary, women or men, and may have a chronic 
disease. The information included in this article jumps from fact to fact with very little or 
no evidence to support the claims made. While providing many different links that sell 
green tea products.97 
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CHAPTER 3 
METHODS  
SUBJECT SELECTION  
Subjects who were eligible for this study was 18+ years of age, healthy, and not on any 
medications that can alter blood glucose levels. An online survey was used to recruit 
ASU students and faculty. The study was approved by the IRB at ASU (see appendix A) 
and written consent was obtained (see appendix B for consent form). Once consent forms 
were signed, health history questionnaires were given, and anthropometrics was taken. 
(see appendix C for health history questionnaire)  
 STUDY DESIGHN AND PROCEDURE   
This study was a 3-week, randomized controlled, single blinded, crossover study in 12 
healthy subjects. The sample size was calculated using the Harvard sample size calculator 
(see appendix D).  Subjects were block randomized for three treatments: control, Lipton 
green tea, and Matcha tea. All subjects were given a bagel to consume with dinner the 
night before. Participants were asked to not drink coffee or participate in high or 
moderate intensity exercise the day before the study. Subjects were asked to fast (no food 
or beverage with the exception of water) for 10 hours overnight.  Subjects reported to the 
test site for about 2.5 hours. Subjects were in three different treatment groups. The first 
week some subjects consumed a bagel and water (control), a bagel and Lipton Green Tea, 
or a bagel and Matcha Tea. For the next two visits, they were in different groups to 
complete all treatments. The food and beverages used in this study include the 
commercially available Lipton tea (Lipton, Pure Green Tea, Unilever, Englewood Cliffs, 
NJ) one tea bag. The Matcha green tea used (Ceremonial Matcha, Marukyo-Koyamaen, 
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Uji, Kyoto, Japan). The following items were used: plain bagel (Chompies, Tempe, AZ), 
Strawberry Jam (Smucker’s, Orrville, OH), and bottled water (Arrowhead, Chandler, 
AZ). Meals were prepared for all subjects which included a toasted bagel with 14g of jam 
and a water bottle. Lastly, depending on what group the subject was in that morning they 
receive either 240ml of water, 1 Lipton tea bag in 240 mL water or 1 teaspoon of Matcha 
in 240mL of water. To prepare the Lipton tea, a kettle with water was heated till the 
water boiled. The Lipton tea bag was added to a mug and 240 mL of the water was 
measured. Once the 240 mL of water was cooled at a temperature between 158-176°F, 
the water was poured over the teabag. A teaspoon of powdered Matcha was sifted 
through a fine strainer into a mug. Water was added to a kettle and brought to a boil. The 
240 mL of the water was measured and once the temperature cooled to 158-176°F, the 
water was added to the bowl. The water and Matcha were mixed together with a bamboo 
whisk till the tea had a frothy layer on top. Subjects were assigned a calibrated 
glucometer (ACCU-CHEK, Aviva meter system, Indianapolis, IN). To calibrate the 
glucometer, turn the glucometer on, stick the test strip into glucometer. Using two 
different control solutions while wearing gloves add one drop of each solution to the 
fingertip and place test strip attached to glucometer towards the solution to be absorbed 
by the strip. The glucometer will read the liquid and the measurement should fall within 
the numbers that are on the bottle. Once this is done for both liquids the glucometer is 
calibrated. The subjects were assigned a glucometer using the number written on it. The 
glucometer was assigned to each subject, so each visit the same glucometer is used. Once 
the subject comes in they sat down, and their fasting blood glucose was taken. The finger 
was first cleaned with alcohol swab, and then pricked using a disposable lancing device. 
  40 
The finger was massaged if needed to get the first drop of blood, which was then wiped 
away with a cotton swab. Then the finger was massaged again to get the second drop of 
blood which was tested using the test strip which was attached to the glucometer. Fasting 
blood glucose were recorded. The meals were then served to each subject blood glucose 
measurements were taken 30 mins after the first bite and continuing every 30 mins till 
120 minutes was reached (see appendix E for flow chart).  
STATISTACLE ANALYSIS  
Data is presented Mean±SD, checked for normality, and transformed if necessary.  The 
repeated measure ANOVA statistical test was used to assess differences between means 
over time using the Statistical Package for the Social Sciences (SPSS 2.0) software. Level 
of probability is P= < 0.05.  The area-under-the curve for the glycemic response was 
computed using the Trapezoidal Rule and compared by treatment.   
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CHAPTER 4 
RESULTS 
Recruitment for subjects who were healthy men and women 18 years or 
older not on any medications that would alter blood glucose levels took place 
February 2017 at Arizona State University. Survey was open from February 
3rd to February 15th, 2017. There were 28 people who answered survey 
monkey, and all respondents qualified but one who was vegan. Since bagels 
are not a vegan product, this volunteer would not qualify. Of the 27 subjects 
only 17 responded to the email and within two weeks 14 subjects were 
screened and signed the consent form. All subjects who were screened 
qualified for the study. Two subjects did not show on the day they were 
scheduled to come in therefore, there were only 12 subjects who participated 
and completed the study. Participant characteristics are displayed in Table 1.  
All participants were healthy, non-diabetic, and nonsmokers. Mean age was 
23.8 ± 3.1 with a mean BMI (kg/m2) of 23.9 ± 5.7, height (cm) 164.7 ± 6.8, 
weight (kg) 65.3 ± 20.2 and a waist circumference (cm) 76.5 ± 16.    
Table 2. Sample Characteristics 
Subject gender age 
Height 
(cm) 
weight 
(kg) 
BMI 
(Kg/m2) 
waist 
(cm) 
1 F 31 169.5 61.8 21.6 73.2 
3 F 21 159.0 60.6 24.0 75.9 
4 F 20 165.0 62.3 22.9 73.7 
5 F 25 164.0 53.8 20.0 66.0 
6 F 21 161.0 47.2 18.2 63.5 
8 F 21 159.0 56.3 22.3 73.7 
9 F 25 168.0 62.6 22.2 73.7 
10 M 25 158.0 61.2 24.5 78.7 
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Subjects were randomly selected to either water (Control), Matcha tea or Lipton tea 
(Treatment). This is a crossover study therefore all subjects consumed all three beverages 
about a week apart. The data collected can be seen in Table 2. Which includes the mean ± 
standard deviation of glucose concentrations for all three beverages at 0, 30, 60, 90, 120 
minutes. At 0 minutes the mean ± SD of glucose concentration for water, Match tea and 
Lipton tea was 89.1 ± 6.2, 92.4 ±7.8, and 90.4 ± 7.8 respectively. At 30 minutes mean 
glucose concentration for water, Match tea and Lipton was 133.3 ± 15.5, 132.6 ± 17.8, 
and 131.0 ± 12.2 respectively. At 60 minutes mean glucose concentration for water, 
Match tea and Lipton tea was 119.5 ± 13.8, 125.3 ± 16. 9, and 125.0 ± 13.7 respectively. 
At 90 minutes mean glucose concentration for water, Match tea and Lipton was 112.5 ± 
12.4, 115.8 ± 15.9, and 115.0 ± 13.1 respectively. At 120 minutes mean glucose 
concentration for water, Match tea and Lipton tea was 105.2 ± 9.6, 112.3 ± 18.1, and 
106.3 ± 12.9 respectively. Using repeated measure ANOVA to assess differences 
between means over time. The area-under-the curve for the glycemic response was 
computed using the Trapezoidal Rule and compared by treatment. The glycemic curve 
for all three beverages showed no statistically significant difference with a p-value of 
0.960. The glycemic curve which can be seen in table 3. Shows the glycemic response 
after consuming each beverage and a bagel. All curves showing a very similar glycemic 
11 F 26 160.0 67.6 26.4 74.9 
13 M 23 177.0 127.2 40.6 125.7 
14 F 25 159.0 57.6 22.8 67.8 
15 F 22 177 65.8 21 71.1 
Mean  
23.8 ± 
3.1 
164.7 ± 
6.8 
65.3 ± 
20.2 
23.9 ± 
5.7 
76.5 
± 16 
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response to each beverage (p= 0.960). A p-value of 0.960 inhibits the ability to look at 
the differences between the different times.    
Table 3. Mean Glucose Concentrations at 0, 30, 60, and 120 Minutes  
minutes  Water Matcha  Lipton  p-value 
0 89.1 ± 6.2 92.4 ±7.8 90.4 ± 7.8 0.960 
30 133.3 ± 15.5 132.6 ± 17.8 131.0 ± 12.2  
60 119.5 ± 13.7 125.3 ± 16. 9 125.0 ± 13.7  
90 112.5 ± 12.4 115.8 ± 15.9 115.0 ± 13.1  
120 105.2 ± 9.6 112.2 ± 18.1 106.3 ± 12.9  
*All means are reported as mean ± standard deviation. P value using repeated measure ANOVA. 
Significant at p<0.05.  
 
 
Figure 1. Glycemic Curve for all Three Beverages  
 
Figure 1. A comparison of the mean blood glucose measurements after 
consuming either water, Lipton tea, and Matcha tea at 0, 30, 60, 90, and 120 
minutes. Data includes all subjects who have completed this study (n=12). 
Significant at p <0.05.    
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CHAPTER 5 
DISCUSSION 
The polyphenols in green tea, particularly EGCG, have been found to decrease 
postprandial glucose concentrations in mice. Many studies have seen inhibitory effects of 
EGCG on α-amylase, an important enzyme in the breakdown of carbohydrates.32, 34, 61 
This randomized controlled, single blinded, crossover study looked at the effects of 
Matcha tea as well as Lipton tea ingestion at meal-time on the 2-h postprandial glucose 
response. Twelve healthy subjects completed all arms of the crossover study. There were 
no statistically significant findings (P=0.960) between the test conditions which included 
the control (water) and the two treatment groups (Lipton tea and Matcha tea). A study by 
Forester et al, had shown that 100 mg/kg of EGCG given to mice consuming common 
corn starch decreased blood glucose concentrations by 73 mg/dl at 60 minutes compared 
to the control. Other studies in humans have not been able to show the same findings. 
One study in humans looked at green tea on postprandial glucose concentrations in 14 
healthy subjects. The subjects consumed either 300 ml of water or tea and a test meal 
composed of white bread (50 g carbohydrate) and turkey.48 The tea was prepared using 
9.00 g of loose leaf green tea seeped in 300 ml of hot water.48 There was no statistically 
significant decrease in postprandial glucose concentrations in either group. Hence, 
although direct supplementation with 100 mg/kg EGCG was associated with an 
antiglycemic response in mice, human trials indicate that green tea, when taken in 
customary amounts, does not possess antiglycemic properties at mealtime.   
Matcha tea was used in this study since there are no studies to our knowledge on 
powdered green tea. Consuming the plant whole would provide all the nutritional 
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contents of tea; yet, this manner of ingestion did not provide any measurable effect.  
Limitations in this study included the small sample size.  Moreover, the amount EGCG in 
1 Lipton tea bag or 1 teaspoon of Matcha tea is not known. Based on one website called 
consumer lab, which had tested both Matcha tea and brewed green tea. They found that 
per 1 g of Matcha tea and brewed green tea there were 50-55 mg and 20 to 40 mg of 
EGCG respectively.19 In this study 1 teaspoon of Matcha tea was used which is about 2 g. 
The 12 subjects could have consumed from 100-110 mg of EGCG in the Matcha tea. Still 
this is not an exact amount; and since the processing of these teas effects EGCG levels it 
would have been an important factor to determine in this study. Also, on a weight per 
weight basis, humans might need a higher dose of EGCG to produce the same effects in 
mice. Such a high amount would need to be provided as a supplement. Providing exact 
amounts of EGCG and including different dosage of EGCG for example 100 mg, 200 
mg, 300 mg and so on could have helped strengthened this study.   
Although, the inhibitory effects of EGCG on α-amylase has been found in many 
studies. Other studies have still not been able to consistently prove green tea to be 
effective in lowering postprandial glucose concentrations. Still, many websites make the 
claims that green tea helps in the management and prevention of diabetes. Some make the 
claim that it could help lower glucose concentrations, yet the studies used to support such 
claims talk about caffeine content or use green tea extract. These claims mislead those 
who read these web articles and do not look at the science behind such claims. These web 
articles are sending false information and/or selling green tea products. It is important for 
these individuals to get the accurate information so that they can make informed 
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decisions.  There are other dietary strategies to lower postprandial glucose 
concentrations.  These include vinegar, nuts, and exercise.   
Vinegar has been found be very effective in lowering postprandial glucose 
concentrations in many studies. 47, 58, 70 The acetic acid delays gastric emptying and 
therefore slows down the digestion and absorption of a carbohydrate. 58, 63 Slower 
digestion and absorption lowers the GI of a carbohydrate and prevents a spike in glucose 
concentrations. In one study subjects were to drink a test drink (20g of apple cider 
vinegar) which provided 5% acetic acid or a placebo drink.47 Once the beverage was 
consumed the subjects would eat a bagel with butter, juice and water. The GI of this meal 
was 100. After 60 minutes from consuming the meal the PPG concentrations were 
lowered by 54% compared to the placebo drink. Vinegar has shown to significantly 
decrease in PPG concentrations in this study and many other studies. Acetic acid has also 
been found to inhibit the enzymes in the brush boarder of the small intestine. These 
enzymes are known as disaccharidase. They are responsible for the breakdown of 
disaccharides sucrose, maltose, and lactose into monosaccharides. With an inhibition of 
these enzymes decreases the amount of glucose in the blood after a meal.63  
Nuts also has been found to decrease PPG concentrations.46, 47, 49 Nuts slow the 
rate of gastric emptying therefore slowing digestion and absorption of carbohydrates.49 In 
one study subjects consumed either a bagel with butter or a bagel with 25g of peanut 
butter.  PPG concentrations was lowered by 56% when consuming the bagel with peanut 
butter compared to just eating a bagel and butter.47 Another study had subjects consume 
white bread and different amounts of almonds. For example, 0g (control) or 30g, 60g, 0r 
90g.49 The study found that the higher the dose of almonds the lower the PPG 
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concentrations due to slower gastric emptying and a decrease in the GI of the white 
bread.49     
Exercise is another intervention that has effects on lowering PPG concentrations. 
Exercise for 90 minutes (moderate-intensity) 2-hours before or after a meal has been 
found to decrease PPG concentrations by 50%.68 Physical activity has been shown to 
reduce PPG concentrations for up to 48 hours.1, 77 This could be due to increased insulin 
sensitivity, which allows the cells of a muscle or adipose tissue to respond to insulin more 
efficiently and increasing the uptake of glucose.1 
Although, Matcha tea which is essentially green tea in powder form has not 
shown an antiglycemic effects in this study. EGCG a polyphenol most abundant in green 
tea has been linked with cancer prevention. Many animal studies have found EGCG to 
inhibit tumorigenesis in the oral cavity, esophagus, stomach, small intestine, colon, liver, 
pancreas, lung, bladder, prostate, mammary glands and skin.96 In more than 30 studies the 
catechins found in tea has inhibited tumorigenesis in genetically induced animals in the 
oral cavity, esophagus, stomach, small intestine and colon.96 Oxidative stress is 
associated with tumorigenesis and phytochemicals like EGCG reduces oxidative stress 
therefore inhibiting tumorigenesis.17 Oxidative stress has been linked to the development 
of cancer which includes three stages: initiation, promotion, and progression.17 For 
example, oxidative stress can initiate cancer by causing mutations in oncogenes and 
tumor-suppressor genes.17 One study looked at 133 smokers and the effects of green or 
black tea consumption on oxidative DNA damage. Smoking contains many compounds 
that can induce ROS production that causes oxidative damage to the DNA. The repair of 
oxidative damage to the DNA can be measured by the urinary excretion of 8-OHdG.41 
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Subjects consumed either 4 cups/d of green or black tea or water for 4 months. Urinary 8-
OHdG was decreased by 31% in those consuming the green tea. Those consuming the 
black tea and water showed no difference. The study concluded that green tea 
consumption may protect smokers from oxidative damage and decrease the risk of 
cancer.41 In a prospective cohort study of Japanese population which surveyed 8,552 
individuals over 40 years old.44 The study looked at relative risk of cancer incidents 
based on green tea consumption which showed a RR of .53 in non-smoker who 
consumed 10 or more cups of green tea a day and a RR of .73 was found in smokers who 
consumed 10 or more cups of green tea a day.44 A study in Italy with 60 men who had 
high-grade prostate intraepithelial. Studies have found that those with high-grade prostate 
intraepithelial increased their chances of developing prostate cancer within 1 year by 
30%.8 For 12 months 30 subjects consumed a total of 600 mg/day of green tea catechins. 
Results found only one subject developed prostate cancer in this group, compared to 9 
out of the 30 men who took the placebo.8, 96 Still many human studies both 
epidemiological and RCT have found inconsistent results.96   
EGCG acts as an antioxidant due to its ability to reduce reactive oxygen species 
(ROS) that can be linked to many diseases like cardiovascular disease. 96 EGCG’s ability 
to act as an antioxidant makes drinking tea an important staple for our health. ROS is 
produced naturally in the body when we metabolize food which then produces energy 
which leads to ROS production. The removal of ROS is an important and necessary role 
for antioxidants. As ROS build up in the cell also known as oxidative stress it can 
damage the cells in the body due to its ability to attack polyunsaturated fatty acids in the 
cell membrane and DNA lipid and proteins which can lead to disease like cancer and 
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cardiovascular disease.17, 96 In diabetes hyperglycemia can increase ROS production. If 
there are not enough antioxidants to reduce ROS in the cell causing oxidative stress it can 
lead to other diseases like cardiovascular disease, specifically atherosclerosis.  
Antioxidants are important in the prevention of such diseases by keeping ROS levels 
low.96 EGCG has been found to reduce LDL-C as well. In one study EGCG was given at 
different doses from 107-857 mg/d in 1356 healthy subjects for 3 to 14 weeks. Those 
receiving the EGCG with either dosing showed a significant decrease in LDL-C.64, 96 
These findings show that decreasing LDL-C can help prevent cardiovascular disease, due 
to LDL-C large role in atherosclerosis.64, 96 EGCG has also been found to inhibit NF-KB 
activation. NF-KB can be activated by ROS. NF-KB activates pro-inflammatory 
cytokines that play a role in atherosclerosis.96    
In conclusion, even though this study did not find antiglycemic effects in Matcha 
tea consumption. There have been many studies that support the benefits of polyphenols 
specifically EGCG in tea which act as an antioxidant. Antioxidants are important in 
reducing oxidative stress and therefore green tea has protective properties to the body’s 
cells and DNA. Green tea should be included in an individual’s diet due to its potential 
anti-cancer effects and its ability to reduce oxidative stress.    
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MATCHA TEA AND ITS ACUTE EFFECTS ON POSTPRANDIAL BLOOD 
GLUCOSE 
The purposes of this form are (1) to provide you with information that may affect your decision 
as to whether or not to participate in this research study, and (2) to record your consent if you 
choose to be involved in this study. 
RESEARCHERS 
Dr. Carol Johnston, a Nutrition professor at Arizona State University Downtown Campus, and 
Roni Romash, a nutrition graduate student, have requested your participation in a research 
study. 
STUDY PURPOSE 
The purpose of the research is to examine the effects of tea ingestion on post-meal rise in 
blood glucose.  Blood glucose will be measured via finger pricks.   
DESCRIPTION OF RESEARCH STUDY 
You have indicated to us that you are 18 years of age and generally healthy.  You have not 
been diagnosed with diabetes and you do not take diabetic medications including insulin.  If 
female you have not recently been pregnant or lactating.  Lastly, you are not gluten-
sensitive.  Participants will be asked to maintain their usual diet and physical activity level 
throughout the trial with the exception of the day prior to testing. This study will initially 
involve the completion of a brief medical history questionnaire to demonstrate the absence 
of medical conditions that may impact the study.  Your weight, height, and girth will be 
measured at this time.  This first meeting will take <20 minutes.  There are three additional 
visits (e.g., the test days) that will last about 2.5 hours each and scheduled a week or two 
apart. The procedures on all test days are identical.  On the day prior to testing you are asked 
to avoid exercise (normal activities such as walking to work or walking the dog is ok).  You 
will be asked to eat a normal breakfast and to consume a bagel with lunch and with dinner. 
These bagels will be given to you.  Following dinner, you will fast overnight and not 
consume any food or beverage with the exception of water.  On test days, you will travel to 
ASU (the Nutrition labs at the ABC1 Building on the ASU Downtown campus) early in the 
morning.  Your finger will be pricked for a blood sample.  You will then consume either tea 
or water and a test meal (bagel with jam).  Your finger will be pricked 4 more times over the 
next 2 hours.  You may drink water during these two hours but you are not to consume any 
other food or beverage.  You may read, study, or work on the computer at the test site.  Once 
testing is complete, you may proceed with your normal activities.  About 15 subjects will 
participate in this study. 
 
Finger pricks will be conducted under sterile conditions using disposable, retractable lancets.  
Blood samples will be analyzed for glucose.   
RISKS 
Bruising of the skin or a feeling of faintness is possible during the blood draws. A registered 
nurse will draw the venous blood sample under sterile conditions and is trained to minimize 
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these risks.  For the finger pricks, disposable retractable lancets will be used and sterile 
conditions will be used.   
 
BENEFITS  
There is no direct benefit for participating in this trial.  If desired, you will be given your 
blood glucose values.    
NEW INFORMATION 
If the researchers find new information during the study that would reasonably change your 
decision about participating, then they will provide this information to you.  
CONFIDENTIALITY 
All information obtained in this study is strictly confidential unless disclosure is required by 
law.  The results of this research study may be used in reports, presentations, and publications, 
but your name or identity will not be revealed.  In order to maintain confidentiality of your 
records, Dr. Johnston will use subject codes on all data collected, maintain a master list 
separate and secure from all data collected, and limit access to all confidential information to 
the study investigators.  Plasma from blood samples will be stored for 5 years in freezers in 
the laboratories of the Nutrition Program at Arizona State University Downtown Campus after 
which time they will be disposed of as biohazard waste. 
WITHDRAWAL PRIVILEGE 
You may withdraw from the study at any time for any reason without penalty or prejudice 
toward you.  Your decision will not incur negative treatment to you by the researchers. 
COSTS AND PAYMENTS 
The all test foods will be given to you during the study free of charge.  You may need to pay 
for parking meters during the visits.   
COMPENSATION FOR ILLNESS AND INJURY 
If you agree to participate in the study, then your consent does not waive any of your legal 
rights. However, in the event of harm, injury, or illness arising from this study, neither Arizona 
State University nor the researchers are able to give you any money, insurance coverage, free 
medical care, or any compensation for such injury.  Major injury is not likely but if necessary, 
a call to 911 will be placed.  
VOLUNTARY CONSENT 
Any questions you have concerning the research study or your participation in the study, 
before or after your consent, will be answered by Dr. Carol Johnston; 500 N. 3rd Street 
Phoenix, AZ 85004; 602-827-2265.  
If you have questions about your rights as a subject/participant in this research, or if you feel 
you have been placed at risk, you can contact the Chair of the Human Subjects Institutional 
Review Board, through the ASU Research Compliance Office, at 480-965 6788.   
This form explains the nature, demands, benefits and any risk of the project.  By signing this 
form you agree knowingly to assume any risks involved.  Remember, your participation is 
voluntary.  You may choose not to participate or to withdraw your consent and discontinue 
participation at any time without penalty or loss of benefit.  In signing this consent form, you 
are not waiving any legal claims, rights, or remedies.  A copy of this consent form will be 
given to you.   
 
Your signature below indicates that you consent to participate in the above study.   
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___________________________ _________________________ ____________ 
Subject's Signature   Printed Name    Date 
___________________________ _________________________       
Contact phone number              Email    
INVESTIGATOR’S STATEMENT 
"I certify that I have explained to the above individual the nature and purpose, the potential 
benefits, and possible risks associated with participation in this research study, have answered 
any questions that have been raised, and have witnessed the above signature. These elements 
of Informed Consent conform to the Assurance given by Arizona State University to the Office 
for Human Research Protections to protect the rights of human subjects. I have provided the 
subject/participant a copy of this signed consent document." 
Signature of Investigator____________________________________        
Date_____________ 
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ID#___________________ 
Height ________ft. ____in.         Weight: _________lbs.             
 
Age: __________                   
Gender:   □ Male   □ Female           
 Smoker:  □Yes     □ No         
 
1. Have you been diagnosed with pre-diabetes or diabetes?                           Y
 N     
 
2.  Have you been diagnosed with other chronic diseases (such as                Y 
 N                                      heart disease, neurological disease, autoimmune 
disease, or cancer)?                                                 
 
3. Do you take any medications regularly?                                    Y
 N 
    Please list what kind and how frequently:  
 
Medication    Dosage   
 Frequency 
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
__ 
 
4. Do you currently take supplements (vitamins, minerals, herbs, etc.)?                             
Y       N 
              If yes, what supplements and how often?  
              
________________________________________________________________
______ 
              
________________________________________________________________
______ 
              
________________________________________________________________
______ 
              
________________________________________________________________
______ 
Waist:  ___________  ins. 
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________________________________________________________________
______ 
  
5.   Do you have medical conditions that you see a physician for on a regular 
basis?         Y       N   
              Please explain:   
              
________________________________________________________________
______ 
              
________________________________________________________________
______ 
              
________________________________________________________________
______ 
              
________________________________________________________________
______ 
              
________________________________________________________________
______                                                                 
                                                                     OVER  
 
 
6.  Do you have any food allergies including a gluten sensitivity?                                    
Y       N 
             If yes, please describe 
_____________________________________________________ 
                                                 
_____________________________________________________ 
 
7.  Do you follow a special diet? (weight gain/loss, vegetarian, gluten-free etc.) 
       Y       N 
             If yes, please describe 
___________________________________________________________ 
                                                 
___________________________________________________________ 
                                                  
 
8. Will you have any problems fasting for 12 hours prior to testing sessions?                    
Y       N 
 
9. Do you have any difficulty chewing or swallowing?                                                       
Y       N 
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10. Are you OK with drinking tea and eating bagels and strawberry jam?                          
Y       N 
 
11. Will you have a problem (such as fainting) providing blood samples?  
      (5 finger pricks per test day)                                                                                           
Y       N 
 
12.  If you drink alcohol or caffeine, will you be able to abstain from these  
       beverages for the 24-hour periods prior to test days?                                                   
Y       N 
 
13.  If you exercise regularly, will you be able to not exercise (other than basic 
       walking and work activity ) for the 24-hour period prior to testing?                             
Y       N 
 
14.  Please circle the number of times you did the following kinds of  
       exercises for more than 15 minutes last week. 
 
Mild exercise (minimal effort):   
Easy walking, golf, gardening, bowling, yoga, fishing, horseshoes, archery, 
etc. 
 
Times per week:     0   1   2   3   4   5   6   7   8   9   10   11  12   13   14+ 
  
Moderate exercise (not exhausting):   
Fast walking, easy bicycling, tennis, easy swimming, badminton, dancing, 
volleyball, baseball, etc. 
 
Times per week:     0   1   2   3   4   5   6   7   8   9   10   11  12   13   14+ 
  
Strenuous exercise  activities (heart beats rapidly):   
Running, jogging, hockey, football, soccer, squash, basketball, cross country 
skiing, judo, roller skating, vigorous swimming, vigorous long distance 
bicycling, etc. 
 
Times per week:     0   1   2   3   4   5   6   7   8   9   10   11  12   13   14+ 
 
          
Please describe any other conditions or medical reasons that may affect your 
participation below:   
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Author Year PPG 
change 
n per 
group 
Calculated 
n per 
group 
Age 
range 
Subject 
State 
Test 
Nyambe-
Silavwe 
et al 
2015 27.4±7.52 16 6 22-30 Healthy  Low 
dose 
PFRF & 
PPG 
Nyambe-
Silavwe 
et al 
2015 49±15.3 16 6 22-30 Healthy High 
dose 
PFRF & 
PPG 
Johnston 
et al 
2015 54±1.98 11 4 25-31 Healthy Vinegar 
PPG at 
60mins 
Johnston 
et al 
2015 
56±.66 
11 4 25-31 Healthy Peanuts 
PPG at 
60mins 
Average  47±6.4 14 5 24-31   
All data is represented as means ±SD 
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